Lv51
1010 积分 2023-09-07 加入
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK-029A in Treatment-Naive Patients With Advanced NSCLC Harboring EGFR Exon 20 Insertion Mutations: A Phase 1 Trial
5天前
已完结
Stimulation of cGAS-STING pathway as a challenge in the treatment of small cell lung cancer: a feasible strategy?
11天前
已完结
Safety and efficacy of complement factor H (CFH) inhibitor GT103 in advanced non-small cell lung cancer (NSCLC): Results of a phase Ib first in human dose escalation study
12天前
已关闭
A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients
13天前
已完结
Immunogenicity and Efficacy of Personalized Adjuvant mRNA Cancer Vaccines
13天前
已完结
Targeting KRAS G12C mutation in lung adenocarcinoma
16天前
已完结
Efficacy and safety of KRAS G12C inhibitor IBI351 monotherapy in patients with advanced non-small cell lung cancer: results from a phase 2 pivotal study
16天前
已完结
Immune checkpoint inhibitors plus platinum-based chemotherapy compared to platinum-based chemotherapy with or without bevacizumab for first-line treatment of older people with advanced non-small cell lung cancer
19天前
已完结
The role of PD-L1 in patients with non-small cell lung cancer receiving neoadjuvant immune checkpoint inhibitor plus chemotherapy: a meta-analysis
19天前
已关闭
A current comprehensive role of immune-checkpoint inhibitors in resectable non-small cell lung cancer: A narrative review
19天前
已完结
皖公网安备34019202002308
